Biotech Ready to Strike Up a Conversation on Dealmaking
By Jennifer Boggs
Tuesday, May 3, 2011
SAN FRANCISCO Chatter in the biotech-sphere over the past year has centered on the current economic environment, health care pricing pressure and the fallout from large-scale acquisitions, all of which have converged to make business development a challenging mission, to say the least.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.